Marek Ciszewski, JD

Chief Financial Officer

Marek Ciszewski, JD, 25 years of biopharma and financial industry expertise, encompassing investor relations and managing capital structures for biotech companies. Prior to joining NImmune, Mr. Ciszewski served in leadership positions of increasing responsibility within Investor Relations, Financial Strategy and Corporate Development at Landos Biopharma (NASDAQ: LABP), Lantern Pharma (NASDAQ: LTRN), Epirus Biopharmaceuticals (NASDAQ: EPRS) and Verastem Oncology (NASDAQ: VSTM). Before working in the biopharma industry, Mr. Ciszewski spent 18 years in the financial industry, most recently as the Head of Equity Research at BMO Global Asset Management, one of the world’s largest asset managers. Mr. Ciszewski received his Juris Doctor degree from Chicago-Kent School of Law. He earned dual B.Sc. degrees in Finance and Economics from DePaul University. Former VP of Financial Strategy and Investor Relations at Landos.